Eli Lilly Launches AI, Machine Learning Platform Called TuneLab For Biotech Companies
Synopsis
The platform will provide biotech companies access to drug discovery models trained on years of Lilly's research data, the company stated.
Eli Lilly and Company (LLY) on Tuesday announced the launch of an artificial intelligence and machine learning platform called Lilly TuneLab.
The platform will provide biotech companies access to drug discovery models trained on years of Lilly's research data, Lilly said, while adding that it includes proprietary data obtained at a cost of over $1 billion. In return for access to the platform, selected biotech partners will contribute training data, which will fuel improvement for the benefit of others in the ecosystem.
Get updates to this developing story <directly on Stocktwits.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.